Navigation Links
Biomarker test shows promise for melanoma diagnosis
Date:1/24/2011

Chapel Hill, NC A new study shows that a test of biomarkers for DNA methylation is technically feasible and could aid in earlier, more precise diagnosis of melanoma.

In a paper that appeared online last week in the journal Pigment Cell & Melanoma Research, a team of UNC researchers tested whether DNA methylation profiling could be accomplished on melanoma and mole tissues that had been preserved in fixatives for typical pathology examination after biopsy. They found that results on tissues prepared in this way were reliable and DNA methylation distinguished malignant melanomas from non-malignant moles.

Melanoma is one of the only forms of cancer that is still on the rise and is the most common form of cancer in young adults. The incidence of melanoma in women under age 30 has increased more than 50 percent since 1980.

"When melanoma is diagnosed early, the prognosis is good. However, once it spreads, it is very difficult to treat. Melanomas and moles can appear similar on the skin and under the microscope making diagnosis of some melanomas difficult. That's why we wanted to determine whether a test for DNA methylation is feasible as a tool for diagnosis," added Nancy Thomas, MD, PhD, professor of dermatology and a member of UNC Lineberger Comprehensive Cancer Center.

Kathleen Conway Dorsey, Ph.D, added, "We are very excited because, with this study, we have shown that this type of testing is feasible and that it has the potential to reliably distinguish between melanoma and benign skin lesions. Devising a molecular test that could aid in the early specific diagnosis of melanoma could have significant benefit for patients." Conway is assistant research professor of epidemiology at UNC's Gillings School of Global Public Health and a member of UNC Lineberger Comprehensive Cancer Center.

The team's research pinpointed sites on 22 genes that have significantly different methylation levels between melanomas and non-melanoma lesions, as well as 12 locations that are highly predictive of melanoma. According to Thomas, another goal of the team is to develop a DNA-methylation test for melanoma tumor DNA that is shed into the bloodstream and that can serve as a measure for disease activity.

"If this test can be developed, it opens the door to diagnose recurrence early and initiate treatment while tumors are more likely to respond to treatment. It would also give us another way to monitor patients for response to treatment and help us better optimize treatments for each patient," Thomas noted.


'/>"/>

Contact: Ellen de Graffenreid
edegraff@med.unc.edu
919-962-3405
University of North Carolina School of Medicine
Source:Eurekalert

Related medicine news :

1. Biomarker may be able to help predict risk of heart failure, cardiovascular death
2. Haptoglobin as an early serum biomarker of virus-induced type 1 diabetes in rats
3. Radiation pharmacogenomics identifies biomarkers that could personalize cancer treatment
4. Mayo researchers find biomarkers for personalizing radiation cancer treatment
5. c-Met may be a biomarker for metastatic hepatocellular carcinoma
6. Novel biomarker may predict response to new VEGF receptor inhibitor
7. Biomarkers May Aid in Early Diagnosis of Alzheimers
8. The cancer biomarker conundrum: Too many false discoveries
9. Biomarkers Could Spot Alzheimers Disease Early, Studies Suggest
10. Hydrophobic proteins: Potential biomarkers for colorectal cancer
11. A prognostic and predictive biomarker for nonsmall cell lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... The ... Quest Awards . The annual awards, now in their 12th year, are among ... selects the winners. , In 2016, the awards were retooled to recognize achievements in ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mlynarek Insurance Agencies, a Detroit ... business owners across eastern Michigan, is connecting with the Oxford/Orion FISH Food Pantry ... , The Oxford/Orion FISH Food Pantry works to ensure homeless, hungry, and underprivileged ...
(Date:3/24/2017)... ... March 24, 2017 , ... Northridge dentists, Dr. ... for sleep apnea and TMJ at their office. TMJ, or temporomandibular joint disorder, ... obstructive type, is increasingly being treated at dental offices with newly developed procedures ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ( ... patients for colonoscopy at the HyGIeaCare® Center that is to be located adjacent ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration ...
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: a dauntless and ... “End Time GPS” is the creation of published author, Wesley Gerboth, a World ... military munitions and space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... YORK and GENEVA , ... announced on World Tuberculosis Day revitalizes efforts to develop ... On World Tuberculosis Day, TB Alliance and ... for the clinical development of sutezolid, an antibiotic drug ... sublicense pertains to the development of sutezolid in combination ...
(Date:3/23/2017)... MOBILE, Ala. , March 23, 2017 Mosaic Life Care, based in ... automate the patient registration process across its network of 58 clinics, located in 22 ... constantly seeking new and innovative ways to improve the delivery of health care to ... Continue Reading ... Mosaic Life Care St. Joseph ...
(Date:3/23/2017)... 2017  Transportation Insight, a multi-modal lead logistics solutions ... management firm with expertise serving clients in the food ... Zaffarano was named a 2017 Food Logistics ... the only publication exclusively dedicated to covering the movement ... "Rick has brought to Transportation Insight a wealth ...
Breaking Medicine Technology: